about
Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysisPerihematomal edema in primary intracerebral hemorrhage is plasma derived.Reduction of Diffusion-Weighted Imaging Contrast of Acute Ischemic Stroke at Short Diffusion Times.Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.Acute stroke imaging. Part I: Fundamentals.The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocolInterpretation and Implementation of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT II).Prognostic evaluation based on cortical vein score difference in stroke.The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome.Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trialPerihematoma cerebral blood flow is unaffected by statin use in acute intracerebral hemorrhage patientsAmelogenins in human developing and mature dental pulpPrehospital systolic blood pressure is higher in acute stroke compared with stroke mimics.Rapid advanced neuroimaging assessment in acute stroke.Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.Advanced imaging in acute stroke management-Part I: Computed tomographic.Perfusion computed tomography in patients with stroke thrombolysis.Thrombolysis in the developing world: is there a role for streptokinase?Factors associated with cognitive decline in transient ischemic attack patients.Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.Blood pressure management in acute intracerebral hemorrhage: current evidence and ongoing controversies.Infarct in a New Territory After Treatment Administration in the ESCAPE Randomized Controlled Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation.Blood-brain barrier compromise does not predict perihematoma edema growth in intracerebral hemorrhage.Acute blood pressure reduction in patients with intracerebral hemorrhage does not result in borderzone region hypoperfusion.Cerebral perfusion and blood pressure do not affect perihematoma edema growth in acute intracerebral hemorrhage.The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial.Safety and feasibility of collateral blood flow augmentation after intravenous thrombolysis.Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes.Surgical clipping or endovascular coiling for unruptured intracranial aneurysms: a pragmatic randomised trial.Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.Novel oral anticoagulant management issues for the stroke clinician.Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial.Cerebral Perfusion Pressure is Maintained in Acute Intracerebral Hemorrhage: A CT Perfusion Study.Insular cortical ischemia is independently associated with acute stress hyperglycemia.Ischemia in intracerebral hemorrhage is associated with leukoaraiosis and hematoma volume, not blood pressure reduction.Ameloblast differentiation in the human developing tooth: effects of extracellular matrices.Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study.Cardiac enzyme elevations after stroke: the importance of specificity.
P50
Q28248328-3DA5EA9A-F26B-4CFA-939A-C994B04723B7Q30936645-3D036FDD-46A9-49D6-AE34-6A833A3CAFBBQ30979091-9031F667-5118-46E5-9412-B428E8BBBFF3Q33210344-AAB35208-16D0-4DBB-AFD9-2B1FB4D30AC3Q33532706-02DB1979-0901-44A0-8ACB-5E02588FC516Q33706535-EF0F7445-9F1A-4D58-B635-D189719ED8F7Q34045411-05A067BA-545C-4A33-9E1D-49372A7843D2Q34150297-84B80F5E-F3CE-4E26-AC06-440DCA7F8E98Q35072884-D61A590F-1ACC-409B-AB0D-F0B0A7056AFFQ35096734-C9028D5B-AE5D-4D0A-9FD7-5D9D8DB58992Q36267268-FF467410-6323-426F-9957-159901E528A2Q36459899-500015CF-947C-41AF-8E23-571418F7A581Q36982018-1976E882-8557-432F-ABBC-14D6770BB7ABQ37453631-D2403B9B-C991-41FE-9D06-BB977C86C9DCQ37459861-CBA5277D-C61C-4D1C-A38E-DFE3AE6605AAQ37637802-B917E87F-0B89-4EF3-8127-D837B61A0E03Q37739884-6792EA42-DC43-42DA-940D-1D30662F5FEBQ38075577-EC7427DC-8526-46F9-ADB1-1650CF5252ECQ38203458-0EEDE8E8-216D-4B18-B514-DEC234378AC2Q38265690-46A1B6A1-7F92-4898-A39A-601F4B4400C0Q38358436-83130070-2168-4161-A62E-60F98A938260Q38384835-75DFDD21-6BAA-4B10-A7DA-5B94C81C02B9Q38405303-1DE95DCE-D1F3-4417-9D57-5D02A9D81828Q38415950-3882E5AC-B3DF-4DAB-95EE-0E4CD6A379A3Q38425039-BC80EB3D-21B3-4B26-8A9A-FD89BA066C51Q38432990-24C0B020-2EF7-4D00-A5EC-5F419700CD51Q38456395-03B6CA8F-DF84-49D9-9C3A-181827B48287Q38494215-75BB7705-D1CB-4AC4-A1F7-3DB605AD7BD4Q38545362-7B3809B3-4E03-44FB-9D6C-1B035CDB98A0Q38716482-DD549994-DF31-4091-9EE9-169E2C796B47Q38771217-2B351508-EA84-4E39-A418-E6DE91E7F6A2Q38910667-57023F7A-8A70-48E2-9FF4-E71FCD193BD9Q39737902-FB47C71C-8C00-402B-8D87-B541C5F9E12AQ39932002-3FC0BCE0-8179-4266-9C15-A4632A694AA6Q40450414-EC86B2EF-37E3-46B5-886B-06D2C2C26C1EQ40504377-84597AB2-E614-442E-8922-68831D8452CEQ41001339-32D31A98-D5A6-4918-A614-76A844559720Q42101081-0F295C0C-367B-4A81-84EB-AAA329F2EFD5Q43497964-5D101BD4-EC2F-4EC4-8F35-0BF089E6FAEBQ44087236-065AFA52-9468-417E-82C2-C07DB75C6CC4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ken Butcher
@ast
Ken Butcher
@en
Ken Butcher
@es
Ken Butcher
@nl
type
label
Ken Butcher
@ast
Ken Butcher
@en
Ken Butcher
@es
Ken Butcher
@nl
prefLabel
Ken Butcher
@ast
Ken Butcher
@en
Ken Butcher
@es
Ken Butcher
@nl
P106
P31
P496
0000-0002-0590-7918